Skip to main content
. 2020 Apr 19;99(6):1241–1249. doi: 10.1007/s00277-020-04018-1

Fig. 3.

Fig. 3

Comparison of the relationships between MR and FACT-Leu domain and aggregated domain scores according to MR level (effect sizea). FACT-G Functional Assessment of Cancer Therapy-General, FACT-Leu Functional Assessment of Cancer Therapy-Leukemia, MMR major molecular response, MR molecular response, TOI trial outcome index.a A (standardized) effect size of 0.2 is considered small (i.e., the difference in means being 0.2 baseline standard deviation units), 0.5 medium, and 0.8 large; a value of ~ 0.1 is trivial; midpoints between values of 0.1, 0.2, 0.5, and 0.8 were used to create categorization intervals for effect size